Q1 2019 Biomarin Pharmaceutical Inc Earnings Call Transcript
Welcome to the BioMarin First Quarter and Full Year 2018 Financial Results Conference Call.
Hosting the conference call today from BioMarin is Traci McCarty, Vice President of Investor Relations. Please go ahead, Traci.
Thank you, Mary. To remind you, this nonconfidential presentations contains forward-looking statements about the business prospects of Biomarin Pharmaceutical Inc. including expectations regarding BioMarin's financial performance, its commercial products and potential future products and different areas of therapeutic research and development. Results may differ materially depending on the progress of Biomarin's product programs, actions of regulatory authority, availability of capital, future actions in the pharmaceutical market and developments by competitors, and those factors detailed in Biomarin's filings with the Securities and Exchange Commission such as 10-Q, 10-K and 8-K report.
On the call from BioMarin's management team today are J.J. Bienaimé, Chairman and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |